Views

Dr Tristan Barber, Chair of the British HIV Association, shares his professional and personal reflections for LGBT+ History Month on the theme of science and innovation.

It’s time to get lenacapavir approved by NHS England and out to people who need it.

Jacqui Stevenson, Senior Policy, Research and Influencing Manager, reflects on prioritising people's quality of life in HIV policy.

We’ve launched the #LetsEndStigma campaign: so you can get behind us in this fight for everyone’s rights.

HIV is considered a disability from the point of diagnosis and therefore is protected under the 2010 Equality Act.

How one nurse's experience of stigma at work led to change for all healthcare workers living with HIV.

It is seven years since PrEP (pre-exposure prophylaxis) was licensed for use in the USA, and three years since we successfully challenged NHS England in the courts on its refusal to consider making PrEP available.

Eighty organisations from across the health sector have issued a consensus statement telling the Government to fund public health.

"My name is Robert and I have HIV. My story is an old one that has come back into the news because of the infected blood inquiry."

NAT and BHIVA have today published new guidance to support HIV care in Immigration Removal Centres (IRCs).

HIV is a women’s issue. Internationally, young women are the group facing the greatest risk of acquiring HIV and in the UK a third of people living with the virus are women.

A new paper published in Eurosurveillance today finds that there has been substantial progress towards achieving the global UNAIDS targets across Europe and Central Asia. Despite this, an estimated 1.2 million people living with HIV still have transmissible levels of the virus because they have been unable to access prevention methods, testing or treatment for HIV. This paper is the first output of nearly two years’ work by NAT as part of the Dublin Declaration monitoring team.